“We'll Examine how the commercialization of this compound fits in with our organization product at Adastra in an effort to posture ourselves to assistance the desire for a safe provide of copyright,” reported chief government officer Michael Forbes in a news launch. The company advised VICE Information it would not be commenting even further.